Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Clinical trial NCT03126071 · UNKNOWN
Trial details
- NCT number
- NCT03126071
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2022-08-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.